DVx Inc. (TYO:3079)

Market Cap	10.60B +21.7%
Revenue (ttm)	55.33B +14.2%
Net Income	309.00M +17.9%
EPS	29.48 +17.6%
Shares Out	10.50M
PE Ratio	34.23
Forward PE	n/a
Dividend	50.00 (4.96%)
Ex-Dividend Date	Mar 30, 2026

Volume	500
Average Volume	2,945
Open	1,000.00
Previous Close	1,009.00
Day's Range	1,000.00 - 1,000.00
52-Week Range	869.00 - 1,820.00
Beta	0.30
RSI	27.25
Earnings Date	May 15, 2026

About DVx Inc.

DVx Inc. engages in the research and development, design, purchasing/selling, import/export, repair, maintenance and inspection, and rental of medical devices and related peripheral devices in Japan. The company offers arrhythmia-related products, such as cardiac pacemakers, implantable cardioverter defibrillators, electrode catheters, and ablation catheters; ischemia-related products, that includes RAQUOS and resolution/resolution SD; and EPS Trainer, an intracardiac electrograms simulator; and wonder belt products. The company also engages in...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1986
• Employees: 334
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 3079

Financial Performance

In fiscal year 2025, DVx Inc.'s revenue was 50.32 billion, an increase of 9.75% compared to the previous year's 45.85 billion. Earnings were 410.00 million, an increase of 138.37%.